Solitary sclerotic fibroma of skin: A possible link with pleomorphic fibroma with immunophenotypic expression for 013 (CD99) and CD34

Journal of Cutaneous Pathology

Volumn 30, Issue 10, 2003, Pages 631-636

  Mahmood, Muhammad N ^a   Salama, Mohamed E ^a   Chaffins, Marsha ^a   Ormsby, Adrian H ^a   Ma, Chan K ^a   Linden, Michael D ^a   Lee, Min W ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 13A; CD31 ANTIGEN; CD34 ANTIGEN; CD68 ANTIGEN; CD99 ANTIGEN; KI 67 ANTIGEN; PROTEIN S 100;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CELL ULTRASTRUCTURE; CLINICAL ARTICLE; DERMATOFIBROMA; FEMALE; FIBROMA; HEMANGIOFIBROMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; PLEOMORPHIC ADENOMA; SKIN BIOPSY; SOLITARY SCLEROTIC FIBROMA; SPINDLE CELL;

ANGIOFIBROMA; ANTIGENS, CD; ANTIGENS, CD34; CELL ADHESION MOLECULES; FIBROMA; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; NAIL DISEASES; SCLEROSIS; SKIN NEOPLASMS; STAINING AND LABELING;

EID: 0242624580     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0560.2003.00126.x     Document Type: Article

References (43)

1. Rapini RP, Golitz LE. Hypocellular fibromas [Abstract]. J Cutan Pathol 1986; 13: 460.
2. Metcalf JS, Maize JC, LeBoit PE. Circumscribed storiform collagenoma (sclerosing fibroma). Am J Dermatopathol 1991; 13: 122.
3. Barax CN, Lebwohl M, Phelps RG. Multiple hamartoma syndrome. J Am Acad Dermatol 1987; 17: 342.
4. Brownstein MH, Mehregan AH, Bikowski JB, Lupulescu A, Patterson JC. The dermatopathology of Cowden's syndrome. Br J Dermatol 1979; 100: 667.
5. Pujol RM, Ravella A, Noguera X, de Moragas JM, Moreno A. Sindrome de hamartomas multiples. Med Cutan Ibero Lat Am 1988; 16: 322.
6. Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997; 15: 356.
7. Starink TM, van der Veen JP, Arwert F, et al. The Cowden syndrome: a clinical and genetic study of 21 patients. Clin Genet 1986; 29: 222.
8. Salem OS, Steck WD. Cowden's disease (multiple hamartoma and neoplastic syndrome): a case report and review of the english literature. J Am Acad Dermatol 1983; 8: 686.
9. Requena L, Gutierrez J, Sanchez-Yus E. Multiple sclerotic fibromas of the skin: a cutaneous marker of Cowden's disease. J Cutan Pathol 1992; 19: 346.
10. Rapini RP, Golitz LE. Sclerotic fibromas of the skin. J Am Acad Dermatol 1989; 20: 266.
11. Lo WL, Wong CK. Solitary sclerotic fibroma. J Cutan Pathol 1990; 17: 269.
12. Starink TM, Meijer CJ, Brownstein MH. The cutaneous pathology of Cowden's disease: new findings. J Cutan Pathol 1985; 12: 83.
13. Donati P, Amantea A, Carducci M, Balus L. Sclerotic (hypocellular) fibromas of skin. Br J Dermatol 1991; 124: 395.
14. Ackerman AB, Ragaz A. The Lives of Lesions: chronology in dermatopathology. New York: Masson, 1984, 36.
15. Ackerman AB. Quandary: sclerotic fibroma. New York: Ardor Scribendi, 2001, 319.
16. McCalmont TH. Sclerotic fibroma: a fossil no longer. J Cutan Pathol 1994; 21: 82.
17. Weary PE, Gorlin RJ, Gentry WC Jr, Comer JE, Greer KE. Multiple hamartoma syndrome (Cowden's disease). Arch Dermatol 1972; 106: 682.
18. Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwartz JF, Shaper JH. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 1984; 133: 157.
19. Nickoloff BJ. The human progenitor cell antigen (CD34) is localized on endothelial cells, dermal dendritic cells, and perifollicular cells in formalin fixed normal skin, and on proliferating endothelial cells and stromal spindle cells in Kaposi's sarcoma. Arch Dermatol 1991; 127: 523.
20. Hanft VN, Shea CR, McNutt NS, Pullitzer D, Horenstein MG, Prieto VG. Expression of CD34 in sclerotic (plywood) fibroma. Am J Dermatopathol 2000; 22: 17.
21. Aiba S, Tabata N, Ishii H, Ootani H, Tagami H. Dermatofibrosarcoma protuberans is a unique fibrohistiocytic tumour expressing CD34. Br J Dermatol 1992; 127: 79.
22. Van de Rijn M, Lombard CM, Rouse RV. Expression of CD34 by solitary fibrous tumors of the pleura, mediastinum and lung. Am J Surg Pathol 1994; 18: 814.
23. Traweek ST, Kandalaft PL, Mehta P, Battifora H. The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia. Am J Clin Pathol 1991; 96: 25.
24. Fletcher CDM. Hemangiopericytoma - a dying breed? Reappraisal of an 'entity' and its variants: a hypothesis. Curr Diagn Pathol 1994; 1: 19.
25. Wilk M, Kaiser HW, Steen KH, Kreysel HW. Das skierotische fibrom. Hautarzt 1995; 46: 413.
26. Shitabata PK, Crouch EC, Fitzgibbon JF, Swanson PE, Adesokan PN, Wick MR. Cutaneous sclerotic fibroma: immunohistochemical evidence of a fibroblastic neoplasm with ongoing type I collagen synthesis. Am J Dermatopathol 1995; 17: 339.
27. Weidner N, Tjoe J. Immunohistochemical profile of monoclonal antibody O13: antibody that recognizes glycoprotein p30/32MIC2 and is useful in diagnosing Ewing's sarcoma and peripheral neuroepithelioma. Am J Surg Pathol 1994; 18: 486.
28. Ambros IM, Ambros PF, Strehl S, Kovar H, Gadner H, Salzer-Kuntschik M. MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration. Cancer 1991; 67: 1886.
29. Biggs C, Rowland J, Crabbe D, Yavari F, Lou YQ, Triche TJ. MIC2 expression in small round cell tumors of childhood. Mod Pathol 1993; 6: 126A.
30. Fellinger EJ, Garin-Chesa P, Glasser DB, Huvos AG, Rettig WJ. Comparison of cell surface antigen HBA71 (p30/32MIC2), neuron specific enolase, and vimentin in the immunohistochemical analysis of Ewing's sarcoma of bone. Am J Surg Pathol 1992; 16: 746.
31. Rettig WJ, Garin-Chesa P, Huvos AG. Ewing's sarcoma: new approaches to histogenesis and molecular plasticity [editorial]. Lab Invest 1992; 66: 133.
32. Fetsch JF, Miettinen M. Sclerosing perineurioma: a clinicopathologic study of 19 cases of a distinctive soft tissue lesion with a predilection for the fingers and palms of young adults. Am J Surg Pathol 1997; 21: 1433.
33. Fetsch JF, Miettinen M. Calcifying aponeurotic fibroma: a clinicopathologic study of 22 cases arising in uncommon sites. Hum Pathol 1998; 29: 1504.
34. Nicholson SA, McDermott MB, Swanson PE, Wick MR. CD99 and cytokeratin-20 in small cell and basaloid tumors of the skin. Appl Immunohistochem Molecul Morphol 2000; 8: 37.
35. Dorfman DM, Kraus M, Perez-Atayde AR, Barnhill RL, Pinkus GS, Granter SR. CD99 (p30/32MIC2) immunoreactivity in the diagnosis of leukemia cutis. Mod Pathol 1997; 10: 283.
36. De Saint Aubain Somerhausen N, Rubin BP, Fletcher CD. Myxoid solitary fibrous tumor: a study of seven cases with emphasis on differential diagnosis. Mod Pathol 1999; 12: 463.
37. Krismann M, Adams H, Jaworska M, Muller KM, Johnen G. Benign solitary fibrous tumor of the thigh: morphological, chromosomal and differential diagnostic aspects. Langenbecks Arch Surg 2000; 385: 521.
38. Zamecnik M, Michal M. Nuchal-type fibroma is positive for CD34 and CD99. Am J Surg Pathol 2001; 25: 970.
39. Diwan AH, Graves ED, King JA, Horenstein MG. Nuchaltype fibroma in two related patients with Gardner's syndrome. Am J Surg Pathol 2000; 24: 1563.
40. Kamino H, Lee JY, Berke A. Pleomorphic fibroma of the skin: a benign neoplasm with cytologic atypia. A clinicopathologic study of eight cases. Am J Surg Pathol 1989; 13: 107.
41. Garcia-Doval I, Casas L, Toribio J. Pleomorphic fibroma of skin, a form of sclerotic fibroma: an immunohistochemical study. Clin Exp Dermatol 1998; 23: 22.
42. Rudolph P, Schubert C, Zeiger BG, Zeiger B, Parwaresch R. Differential expression of CD34 and Ki-Mlp in pleomorphic fibroma and dermatofibroma with monster cells. Am J Dermatopathol 1999; 21: 414.
43. Chen TM, Purohit SK, Wang AR. Pleomorphic sclerotic fibroma: a case report and literature review. Am J Dermatopathol 2002; 24: 54.